Association between PCSK9 Levels and Markers of Inflammation, Oxidative Stress, and Endothelial Dysfunction in a Population of Nondialysis Chronic Kidney Disease Patients

Table 1

Demographic characteristics, clinical and laboratory data, and comorbidities of the 92 CKD patients and the 20 controls.

Parameters	CKD patients ()	Controls [20]
Age (years)
Gender (male), %	51 (55.4%)	6 (30%)
BMI (kg/m^2)
SBP (mmHg)
DPB (mmHg)
Hypertension, %	80 (74%)	0
Diabetes mellitus, %	26 (28.3%)	0
History of CAD, %	25 (27%)	0
Statin treatment, %	33 (36%)	0
eGFR/CKD-EPI (ml/min/1.73 m^2)
UPR (mg/24 h)	323 (140, 1148)	—
T-Chol (mg/dl)
TG (mg/dl)
HDL (mg/dl)
LDL (mg/dl)
Lp(a) (mg/dl)	11.1 (8.0, 29.3)	8 (1-24)
APO-A1 (mg/dl)
APO-B (mg/dl)
Albumin (mg/dl)
Uric acid (mg/dl)
PTH pg/ml	74 (47, 121)	—
Hb (g/dl)
HbA1c (%)	6.1 (5.7, 7.2)	—
LVMI (g/m^2)		—
EF (%)		—
FS (%)		—